Sitaglar M50/500 Tablet 10's
₹97.2*
MRP ₹108
10% off
₹92*
MRP ₹108
15% CB
₹16 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Sitaglar M50/500 Tablet is a combination drug of Sitagliptin (DPP4 inhibitors) and Metformin (Biguanides), belonging to the class of anti-diabetic agents used to treat type II diabetes. Type 2 diabetes is a condition in which either the body stops producing enough insulin (the hormone which helps to decrease sugar levels in the blood), or there is resistance to the action of insulin. As a result, insulin is produced in large amounts, but it cannot act on the body's organs.
Sitagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors that work by increasing the amounts of certain natural substances that lower blood sugar when it is high. Another medicine, Metformin, belongs to the class of biguanides that lower glucose production in the liver, delay glucose absorption from the intestines, and increase the body's sensitivity to insulin. Thus, Sitaglar M50/500 Tablet controls blood glucose levels from rising to very high levels after meals.
Sitaglar M50/500 Tablet should be taken with food to avoid an upset stomach. Sitaglar M50/500 Tablet should be taken at the same time of the day each time for best results. For better advice, your doctor will decide what dose should be taken, and it can change in time depending on your condition. The most common side effect of Sitaglar M50/500 Tablet is hypoglycemia (low blood glucose levels), characterised by dizziness, sweating, palpitations, hunger pangs, dry mouth and skin etc. So, to avoid hypoglycemia, you should not miss meals and should also carry some form of sugar with you. Other side effects include taste change, nausea, diarrhoea, stomach pain, headache, and upper respiratory symptoms.
Sitaglar M50/500 Tablet should not be stopped even if you feel better, without consulting the doctor as your sugar level keeps changing. If you stop taking Sitaglar M50/500 Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Sitaglar M50/500 Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease. Please inform your doctor if you have any type of heart disease, are planning to get pregnant or are breastfeeding.
Sitaglar M50/500 Tablet helps the pancreas produce more insulin, effectively utilise insulin, and decrease the excess sugar the liver makes. It helps control the rise of blood sugar levels after a meal. Besides this, it does not cause weight gain in prolonged use. Sitaglar M50/500 Tablet plays a vital role in controlling blood sugar levels. It prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.
Sitaglar M50/500 Tablet should not be used in patients with type 1 diabetes or with diabetic ketoacidosis. Some diabetic patients, while taking Sitaglar M50/500 Tablet , might develop a rare but serious condition called lactic acidosis. In this condition, too much lactic acid accumulates in the blood, which can damage the workings of your liver and kidneys, which are required to eliminate excess lactic acid from the blood. Before you start taking Sitaglar M50/500 Tablet , tell your doctor if you’ve ever had pancreatitis (inflammation of the pancreas), kidney disease, and low vitamin B12 levels. Sitaglar M50/500 Tablet , when used with insulin, Sitaglar M50/500 Tablet may lower the blood sugar level, leading to hypoglycaemia, which can be fatal. In this case, your doctor may adjust the dose by lowering the insulin dose or Sitaglar M50/500 Tablet . Prolonged intake of Sitaglar M50/500 Tablet may lower your thyroid-stimulating hormone (TSH); hence, an annual check-up of TSH is recommended. In rare cases, you may also develop a serious skin reaction known as bullous pemphigoid that requires immediate medical attention. Tell your doctor if you will have a diagnostic test with an injection of dye or X-ray contrast agent. You should stop using Sitaglar M50/500 Tablet briefly before an X-ray procedure.
Drug-Drug Interactions: Sitaglar M50/500 Tablet interacts with an anti-depressant (bupropion), drugs used to treat glaucoma, antibiotics (cephalexin, ciprofloxacin), anti-acidity drugs (cimetidine), heart condition drugs (digoxin), anti-HIV drugs (dolutegravir), ethanol, saliva reducing drugs (glycopyrrolate), iodinated X-ray contrast agents, anti-epileptic drugs (topiramate, lamotrigine), heart-related chest medicine (ranolazine). Other drug interactions can contribute to increased low blood sugar, including sex hormones (androgens), anti-oxidants (alpha-lipoic acid), pain killers (aspirin), anti-TB drugs (prothionamide), growth hormones (pegvisomant), and other antidiabetic medicines.
Drug-Food Interactions: Intake of excessive alcoholic beverages may increase the chance of a life-threatening condition known as Lactic Acidosis. So, avoid intake of alcoholic beverages with Sitaglar M50/500 Tablet .
Drug-Disease Interactions: People affected with heart diseases (like congestive heart failure and myocardial infarction), Vitamin B12 deficiency, and alcoholism should avoid intake of Sitaglar M50/500 Tablet .
Type 2 diabetes is a condition where the body cannot make sufficient insulin, or the insulin it makes doesn't work properly or is utilized by our body. This can cause high blood sugar levels (hyperglycaemia). Symptoms of type 2 diabetes include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue, and blurred vision. In some cases, there may be weight gain, while in rare cases, weight loss may be observed. The complication of type 2 diabetes also includes neuropathy (nerve problems), nephropathy (kidney problems), retinopathy (damaged retina of eyes or blindness), loss of limbs, sexual dysfunction, and an increase in the chance of heart attack or stroke.
Alcohol
Caution
Avoid consumption of alcohol while on treatment with Sitaglar M50/500 Tablet .
Pregnancy
Caution
Sitaglar M50/500 Tablet is only recommended during pregnancy when the benefit outweighs the risk. Please consult your doctor before starting Sitaglar M50/500 Tablet if you are pregnant or planning to conceive.
Breast Feeding
Caution
Consult your doctor; Sitaglar M50/500 Tablet should be used in breastfeeding mothers only if the benefits outweigh the risks.
Driving
Caution
Drive only if you are physically stable and mentally focussed, If you experience drowsiness after taking these medications you should not drive or operate any machinery or vehicles.
Liver
Caution
If you have or have a history or evidence of any liver-related diseases, please consult the doctor before taking medicine.
Kidney
Caution
If you have or had a history or evidence of any kidney-related diseases, please consult the doctor before taking medicine.
Children
Caution
It is advisable to consult a doctor before using it.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes